SEC Form 4 · accession 0001567619-18-007497
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jay Mazelsky
Officer — Executive Vice President
Period of report
Dec 5, 2018
Accepted (ET)
Dec 7, 2018 · 5:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 5, 2018 | M | 961 | $0.00 | A | 21,820 | D | |
| Common StockF2 | Dec 5, 2018 | F | 446 | $196.80 | D | 21,374 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF4,F3 | — | Dec 5, 2018 | M | 961 | D | — | — | Common Stock | 961 | 7,916 | D |
Explanation of responses
- F1Includes a total of 99 shares of common stock acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 30, 2018, September 30, 2018 and September 28, 2018.
- F2Closing price of Issuer common stock on the NASDAQ market on December 4, 2018.
- F3These restricted stock units were granted to the reporting person on December 5, 2013. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock and vest in five equal annual installments, beginning on the first anniversary date of the date of grant. The number of restricted stock units reported was adjusted to reflect a 2-for-1 stock split in the form of a 100% stock dividend on IDEXX Laboratories, Inc. common stock paid on June 15, 2015.
- F4Not applicable.